Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001415889-25-005753

Chief Financial Officer acquired 112,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Newton Charles W. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-10 Grant or award : show line 1 in the form +112,500 172,725 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-10 Grant or award : show line 2 in the form Option (right to buy) +450,000 450,000 D
2025-02-10 Grant or award : show line 3 in the form Option (right to buy) +56,250 56,250 D
Loading xslF345X05/form4-02272025_120230.xml…